![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.925 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPHC
RNS Number : 4546M
Plant Health Care PLC
12 January 2023
12 January 2023
Plant Health Care plc
("Plant Health Care" or the "Company")
Plant Health Care ("PHC") and Novozymes Announce Distribution Agreement to Commence First Harpin ab Commercial Sales in India
Plant Health Care(R) (AIM: PHC.L) and Novozymes South Asia Pvt. Ltd. ( NASDAQ OMX: NZYM-B) have signed an agreement for the exclusive distribution of Harpin ab for use in sugar cane production in India.
First commercial sales are expected to commence in the second half of 2023, after receipt of the required regulatory approvals. This is the first product introduced into India by PHC. India is the world's second largest producer of sugar cane with about five million hectares under cultivation. Harpin <ALPHA><BETA> has been used on more than 180,000 hectares of sugar cane in Brazil since the launch in 2018.
Evaluated by Novozymes in prior growing seasons in India, the application of Harpin ab to sugar cane bolstered crop yield by more than 10% on average. Harpin <ALPHA><BETA> works by triggering the plant's own self defense systems, in a manner similar to vaccinations in humans, with crops responding with improved quality, nutrient use efficiency, tolerance to abiotic stress and ultimately, increased yield. Being a biological product, Harpin <ALPHA><BETA> has a very favorable human and environmental safety profile.
Jeff Tweedy, CEO of Plant Health Care, said: "Building on the success of our Harpin <ALPHA><BETA> product on sugar cane in Brazil, it was natural to launch the product in India, the world's second largest producer of sugar cane. Novozymes is a leading supplier of biological products to sugar cane processors in India and will be a strong distribution partner for Plant Health Care's technology. Commencing commercial sales in India will materially support continued strong revenue growth at PHC consistent with previously announced aspirations. First sales in India are expected in H2 2023 pending regulatory approvals."
Shanmugam Sambanthan, Novozymes India Commercial Head of Agriculture commented: "Sugarcane production must be increased in order to achieve the transition to cleaner energy sources envisaged under India's National Policy on Biofuels. Novozymes is delighted to be working with Plant Health Care to offer Indian farmers a revolutionary biostimulant, Harpin <ALPHA><BETA>, that enhances sugarcane yield and provides superior economic returns."
For further information, please contact:
Plant Health Care plc Jeff Tweedy, CEO +1 919 926 1600 Cenkos Securities plc - Nomad & Broker Neil McDonald / Pete Lynch +44 (0) 131 220 9771 SEC Newgate (Financial Communications) +44 (0)7540 10666 Robin Tozer / Richard Bicknell phc@secnewgate.co.uk / George Esmond Novozymes Media Relations +45 30 77 05 52 Lina Danstrup, Head of Media Relations lind@novozymes.com
About Plant Health Care
Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.
Find out more at www.planthealthcare.com
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. http://www.novozymes.com
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGREAPFFFFEDEFA
(END) Dow Jones Newswires
January 12, 2023 02:00 ET (07:00 GMT)
1 Year Plant Health Care Chart |
1 Month Plant Health Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions